Ascendiant Capital Markets Forecasts Strong Price Appreciation for Aemetis (NASDAQ:AMTX) Stock

Key Points

• Ascendiant Capital Markets raised its price target on Aemetis from $20 to $21 and maintained a "buy" rating, a bullish call that contrasts with the MarketBeat consensus “Hold” rating and consensus target of $8.58.
• Aemetis opened around $2.93 with a market cap near $195M; it reported a quarterly EPS loss of ($0.24) that beat estimates while revenue of $43.3M missed expectations of $72.1M.
• Institutional ownership is meaningful and rising—Vanguard, Geode, Marshall Wace and State Street increased positions recently, leaving about 27% of shares held by institutions.

Aemetis (NASDAQ:AMTX - Get Free Report) had its price objective boosted by research analysts at Ascendiant Capital Markets from $20.00 to $21.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a "buy" rating on the specialty chemicals company's stock.

AMTX has been the subject of several other research reports. Weiss Ratings restated a "sell (e+)" rating on shares of Aemetis in a research note on Wednesday, January 21st. Wall Street Zen upgraded Aemetis from a "sell" rating to a "hold" rating in a research note on Sunday, March 22nd. Finally, Loop Capital set a $1.75 price objective on Aemetis in a research note on Thursday, March 12th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Aemetis currently has a consensus rating of "Hold" and a consensus target price of $8.58.

Aemetis Stock Performance

Shares of AMTX opened at $2.93 on Wednesday. The stock has a 50-day moving average of $2.03 and a two-hundred day moving average of $1.97. The stock has a market cap of $195.23 million, a P/E ratio of -2.20 and a beta of 1.48. Aemetis has a one year low of $1.22 and a one year high of $3.66.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its quarterly earnings data on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.04. The company had revenue of $43.31 million for the quarter, compared to analysts' expectations of $72.07 million. Analysts predict that Aemetis will post -2.07 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Aemetis by 15.3% during the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company's stock worth $5,578,000 after purchasing an additional 329,760 shares in the last quarter. Geode Capital Management LLC increased its holdings in Aemetis by 5.0% in the fourth quarter. Geode Capital Management LLC now owns 693,453 shares of the specialty chemicals company's stock valued at $964,000 after buying an additional 33,286 shares during the last quarter. Marshall Wace LLP increased its holdings in Aemetis by 289.3% in the fourth quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company's stock valued at $778,000 after buying an additional 415,978 shares during the last quarter. State Street Corp increased its position in shares of Aemetis by 13.9% during the fourth quarter. State Street Corp now owns 260,299 shares of the specialty chemicals company's stock worth $362,000 after purchasing an additional 31,700 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in shares of Aemetis during the second quarter worth about $634,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.